Prithviraj Bose, M.D.

Dr. Prithviraj Bose is a professor and co-leader of the section of myeloproliferative neoplasms (MPNs) within the Department of Leukemia at the MD Anderson Cancer Center in Houston, TX. After obtaining his medical degree from the University of Calcutta in Kolkata, India, where he attended the Calcutta Medical College, Dr. Bose completed an internship in internal medicine at a University of Washington affiliate in Spokane, WA, and residency at the Henry Ford Hospital in Detroit, MI, followed by a fellowship in hematology and oncology at the University of Oklahoma Health Sciences Center in Oklahoma.

In the Department of Leukemia at The University of Texas MD Anderson Cancer Center, which he joined in early 2015, Dr. Bose’s major clinical and research focus is on MPNs. He has authored numerous articles on MPN topics in peer-reviewed journals and books and served on the MPN panel of the National Comprehensive Cancer Network for several years. Dr. Bose is also heavily involved in clinical trial design for patients with MPN, and also in other areas of MPN research. He is leading a number of important therapeutic clinical trials in myelofibrosis, polycythemia vera, essential thrombocythemia and systemic mastocytosis at MDACC. He speaks regularly on MPN topics at regional, national and international meetings, and co-chairs the annual US Focus meeting on MPNs and MDS.